1,136
Views
60
CrossRef citations to date
0
Altmetric
Reviews

Nanoparticles in nanomedicine: a comprehensive updated review on current status, challenges and emerging opportunities

, , &
Pages 414-436 | Received 19 Feb 2021, Accepted 07 Jun 2021, Published online: 05 Jul 2021

References

  • Abdel-Mageed, H., Ezz, N., and Radwan, R., 2019a. Bio-inspired trypsin-chitosan cross-linked enzyme aggregates: a versatile approach for stabilizationthrough carrier-free immobilization. BioTechnologia, 100 (3), 301–309.
  • Abdel-Mageed, H.M., et al., 2012. Development of novel flexible sugar ester vesicles as carrier systems for antioxidant catalase enzyme for wound healing application. Process biochemistry, 47 (7), 1155–1162.
  • Abdel-Mageed, H.M., et al., 2018a. Optimization of nano spray drying parameters for production of α-amylase nanopowder for biotheraputic applications using factorial design. Drying technology, 37 (16), 2152–2160.
  • Abdel-Mageed, H.M., et al., 2018b. Development of novel delivery system for nanoencapsulation of catalase: formulation, characterization, and in vivo evaluation using oxidative skin injury model. Artificial cells, nanomedicine, and biotechnology, 46 (sup1), 362–371.
  • Abdel-Mageed, H.M., et al., 2019b. Bioconjugation as a smart immobilization approach for α-amylase enzyme using stimuli-responsive Eudragit-L100 polymer: a robust biocatalyst for applications in pharmaceutical industry. Artificial cells, nanomedicine, and biotechnology, 47 (1), 2361–2368.
  • Abdel-Mageed, H.M., et al., 2020. Engineering lipase enzyme nano-powder using nano spray dryer BÜCHI B-90: experimental and factorial design approach for a stable biocatalyst production. Journal of pharmaceutical innovation. in press.
  • Abuelezz, N.Z., et al., 2020. Nanocurcumin alleviates insulin resistance and pancreatic deficits in polycystic ovary syndrome rats: insights on PI3K/AkT/mTOR and TNF-α modulations. Life sciences, 256, 118003.
  • Agrawal, M., et al., 2017. Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer’s disease. Journal of control release, 260, 61–77.
  • Alam, M.M., et al., 2017. Endogenous inspired biomineral-installed hyaluronan nanoparticles as pH-responsive carrier of methotrexate for rheumatoid arthritis. Journal of controlled release, 252, 62–72.
  • Agnihotri, S., Mukherji, S., and Mukherji, S., 2014. Size-controlled silver nanoparticles synthesized over the range 5–100 nm using the same protocol and their antibacterial efficacy. RSC advances, 4 (8), 3974–3983.
  • Álvarez, J.V., et al., 2019. Proteomic analysis in Morquio A cells treated with immobilized enzymatic replacement therapy on nanostructured lipid systems. International journal of molecular sciences, 20 (18), 4610–4632.
  • Amendola, V., et al., 2017. Surface plasmon resonance in gold nanoparticles: a review. Journal of physics: condensed matter, 29 (20), 203002.
  • Anderson, S.D., et al., 2019. Cell-penetrating peptides as a tool for the cellular uptake of a genetically modified nitroreductase for use in directed enzyme prodrug therapy. Journal of functional biomaterials, 10 (4), E45.
  • Araújo, R.V., et al., 2018. New advances in general biomedical applications of PAMAM dendrimers. Molecules, 23 (11), 2849.
  • Atlihan-Gundogdu, E., et al., 2020. Recent developments in cancer therapy and diagnosis. Journal of pharmaceutical investigation, 50 (4), 349–361.
  • Aziz, Z., et al., 2019. Role of nanotechnology for design and development of cosmeceutical: application in makeup and skin care. Frontiers in chemistry., 7 (739). PMID: 31799232; PMCID: PMC6863964.
  • Azizian, S., Hadjizadeh, A., and Niknejad, H., 2018. Chitosan-gelatin porous scaffold incorporated with Chitosan nanoparticles for growth factor delivery in tissue engineering. Carbohydrate polymers, 202, 315–322.
  • Baillie, A.J., et al., 1986. Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconate. The journal of pharmacy and pharmacology, 38 (7), 502–505.
  • Batty, C.J., Bachelder, E.M., and Ainslie, K.M., 2021. Historical perspective of clinical nano and microparticle formulations for delivery of therapeutics. Trends in molecular medicine, 27 (6), 516–519.
  • Baumgartner, M., et al., 2017. Spatially and time-resolved magnetization dynamics driven by spin-orbit torques. Nature nanotechnology, 12 (10), 980–986.
  • Bhatt, P., et al., 2018. Liposomes encapsulating native and cyclodextrin enclosed paclitaxel: enhanced loading efficiency and its pharmacokinetic evaluation. International journal of pharmaceutics, 536 (1), 95–107.
  • Bilal, M., et al., 2018. Magnetic nanoparticles as versatile carriers for enzymes immobilization: a review. International journal of biological macromolecules, 120 (Pt B), 2530–2544.
  • Blanco, E., Shen, H., and Ferrari, M., 2015. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nature biotechnology, 33 (9), 941–951.
  • Bobo, D., et al., 2016. Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date. Pharmaceutical research, 33 (10), 2373–2387.
  • Bonifácio, B.V., et al., 2014. Nanotechnology-based drug delivery systems and herbal medicines: a review. International journal of nanomedicine, 9, 1–15.
  • Cai, B., et al., 2016. Autofluorescent gelatin nanoparticles as imaging probes to monitor matrix metalloproteinase metabolism of cancer cells. Journal of biomedical materials research. Part A, 104 (11), 2854–2860.
  • Calzoni, E., et al., 2019. Biocompatible polymer nanoparticles for drug delivery applications in cancer and neurodegenerative disorder therapies. Journal of functional biomaterials, 10 (1), 4.
  • Cardoso, V.F., et al., 2018. Advances in magnetic nanoparticles for biomedical applications. Advanced healthcare materials, 7 (5). doi:10.1002/adhm.201700845.
  • Chauhan, A.S., 2018. Dendrimers for drug delivery. Molecules, 23 (4), 938–947.
  • Chiang, C.S., et al., 2016. Synergistic combination of multistage magnetic guidance and optimized ligand density in targeting a nanoplatform for enhanced cancer therapy. Advanced healthcare materials, 5 (16), 2131–2141.
  • Chiesa, E., et al., 2018. Hyaluronic acid-decorated chitosan nanoparticles for CD44-targeted delivery of Everolimus. International journal of molecular sciences, 19 (8), 2310.
  • Cho, H., 2020. Recent progresses in the development of hyaluronic acid-based nanosystems for tumor-targeted drug delivery and cancer imaging. Journal of pharmaceutical investigation, 50 (2), 115–129.
  • Choi, S.-J., et al., 2013. Toxicity evaluation of inorganic nanoparticles: considerations and challenges. Molecular & cellular toxicology, 9 (3), 205–210.
  • Choi, Y.H. and Han, H., 2018. Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics. Journal of pharmaceutical investigation, 48 (1), 43–60.
  • Clayton, K.N., et al., 2016. Physical characterization of nanoparticle size and surface modification using particle scattering diffusometry. Biomicrofluidics, 10 (5), 054107.
  • Cormode, D.P., Gao, L., and Koo, H., 2018. Emerging biomedical applications of enzyme-like catalytic nanomaterials. Trends in biotechnology, 36 (1), 15–29.
  • Dai, M., et al., 2017. Thermo-responsive magnetic liposomes for hyperthermia-triggered local drug delivery. Journal of microencapsulation, 34 (4), 408–415.
  • Danaei, M., et al., 2018. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics, 10 (2), 57.
  • Dogra, P., et al., 2018. Establishing the effects of mesoporous silica nanoparticle properties on in vivo disposition using imaging-based pharmacokinetics. Nature communications, 9 (1), 4551.
  • Dykman, L.A. and Khlebtsov, N.G., 2011. Gold nanoparticles in biology and medicine: recent advances and prospects. Acta naturae, 3 (2), 34–55.
  • Elechiguerra, J.L., et al., 2005. Interaction of silver nanoparticles with HIV-1. Journal of nanobiotechnology, 3, 6.
  • El-Sherbiny, I.M. and Smyth, H.D., 2011. Smart magnetically responsive hydrogel nanoparticles prepared by a novel aerosol-assisted method for biomedical and drug delivery applications. Journal of nanomaterials, 2011 (2011), 1–13.
  • ETPN. 2021. Nanomedicine European Technology Platform. Src, Ncpm, Ncrd. Strategic agenda for EuroNanoMed. Available from: https://etp-nanomedicine.eu/about-nanomedicine/strategic-research-and-innovation-agenda/
  • Faulk, W.P. and Taylor, G.M., 1971. An immunocolloid method for the electron microscope. Immunochemistry, 8 (11), 1081–1083.
  • FDA. 2020. Drug approvals and databases. Available from: https://www.fda.gov/Drugs/InformationOnDrugs/default.htm [Accessed July 2020].
  • Fowler, B.A., 2009. Monitoring of human populations for early markers of cadmium toxicity: a review. Toxicology and applied pharmacology, 238 (3), 294–300.
  • Gao, L., et al., 2007. Intrinsic peroxidase-like activity of ferromagnetic nanoparticles. Nature nanotechnology, 2 (9), 577–583.
  • Ge, X., et al., 2019. Advances of non-ionic surfactant vesicles (niosomes) and their application in drug delivery. Pharmaceutics, 2911 (2), 55–71.
  • Ghiaci, M., et al., 2016. Silver nanoparticles decorated anchored type ligands as new electrochemical sensors for glucose detection. Journal of the Taiwan Institute of chemical engineers, 63, 39–45.
  • Gobbo, O.L., et al., 2015. Magnetic nanoparticles in cancer theranostics. Theranostics, 5 (11), 1249–1263.
  • Gul, S., et al., 2019. A comprehensive review of magnetic nanomaterials modern day theranostics. Frontiers in materials, 6, 179.
  • Guo, H., et al., 2015. Theranostic magnetoliposomes coated by carboxymethyl dextran with controlled release by low-frequency alternating magnetic field. Carbohydrate polymers, 118, 209–217.
  • Hadiya, S., et al., 2021. Nanoparticles integrating natural and synthetic polymers for in vivo insulin delivery. Pharmaceutical development and technology, 26 (1), 30–40.
  • Handjani-Vila, R., et al., 1979. Dispersions of lamellar phases of non-ionic lipids in cosmetic products. International journal of cosmetic science, 1 (5), 303–314.
  • Hattori, Y., Nakagawa, Y., and Onishi, H., 2019. Gene delivery into hepatic cells with ternary complexes of plasmid DNA, cationic liposomes and apolipoprotein E-derived peptide. Experimental and therapeutic medicine, (4), 2628–2638.
  • He, H., et al., 2019. Survey of clinical translation of cancer nanomedicines-lessons learned from successes and failures. Accounts of chemical research, 52 (9), 2445–2461.
  • Hughes, J.M., et al., 2015. Polymerized high internal phase emulsion monoliths for the chromatographic separation of engineered nanoparticles. Journal of applied polymer science, 132 (1), 41229.
  • Imae, T. and Hamaguchi, S.I., 2012. Network of sodium hyaluronate with nano-knots junction of poly (amido amine) dendrimer. Carbohydrate polymers., 88 (1), 352–360.
  • Israelachvili, J., 1994. The science and applications of emulsions – an overview. Colloids and surfaces A: physicochemical and engineering aspects, 91, 1–98.
  • Jenjob, R., et al., 2019. Emulsion techniques for the production of pharmacological nanoparticles. Macromolecular bioscience, 19 (6), e1900063.
  • Jeon, Y.S., et al., 2019. Metallic Fe-Au barcode nanowires as a simultaneous T cell capturing and cytokine sensing platform for immunoassay at the single-cell level. ACS applied materials & interfaces, 11 (27), 23901–23908.
  • Jiang, Y. and Wu, J., 2019. Recent development in chitosan nanocomposites for surface-based biosensor applications. Electrophoresis, 40 (16–17), 2084–2097.
  • Jin, H., et al., 2019. An amplified label-free electrochemical aptasensor of γ-interferon based on target-induced DNA strand transform of hairpin-to-linear conformation enabling simultaneous capture of redox probe and target. Biosensors & bioelectronics, 145, 111732.
  • Joseph, E. and Singhvi, G., 2019. Multifunctional nanocrystals for cancer therapy: a potential nanocarrier. In: A.M. Grumezescu, ed. Nanomaterials for drug delivery and therapy. William Andrew Publishing, 91–116.
  • Kalantari, M., et al., 2017. Tailoring mesoporous-silica nanoparticles for robust immobilization of lipase and biocatalysis. Nano research, 10 (2), 605–617.
  • Kalaydina, R.V., et al., 2018. Recent advances in “smart” delivery systems for extended drug release in cancer therapy. International journal of nanomedicine, 13, 4727–4745.
  • Kendall, M. and Lynch, I., 2016. Long-term monitoring for nanomedicine implants and drugs. Nature nanotechnology, 11 (3), 206–210.
  • Khan, I., et al., 2015. Nanobiotechnology and its applications in drug delivery system: a review. IET nanobiotechnology, 9 (6), 395–396.
  • Kim, Y., Park, E.J., and Na, D.H., 2018. Recent progress in dendrimer-based nanomedicine development. Archives of pharmacal research, 41 (6), 571–582.
  • Kong, F.-Y., et al., 2017. Unique roles of gold nanoparticles in drug delivery, targeting and imaging applications. Molecules (Basel, Switzerland), 22, 9 (1445).
  • Kouhpanji, M.R.Z. and Stadler, B.J.H., 2020. A guideline for effectively synthesizing and characterizing magnetic nanoparticles for advancing nanobiotechnology: a review. Sensors, 20 (9), 2554.
  • Kundu, M., et al., 2019. pH-responsive and targeted delivery of curcumin via phenylboronic acid-functionalized ZnO nanoparticles for breast cancer therapy. Journal of advanced research, 13, 24–67.
  • Lammers, T., et al., 2020. Dexamethasone nanomedicines for COVID-19. Nature nanotechnology, 15 (8), 622–624.
  • Lee, S.R. and Kim, Y.J., 2018. Hydrophilic chlorin e6-Poly(amidoamine) dendrimer nanoconjugates for enhanced photodynamic therapy. Nanomaterials , 8 (6), 445.
  • Lee, Y. and Thompson, D.H., 2017. Stimuli-responsive liposomes for drug delivery. Nanomed nanobiotechnol, 9 (5), 1450–1490.
  • Li, X., et al., 2016. Current investigations into magnetic nanoparticles for biomedical applications. Journal of biomedical materials research. Part A, 104 (5), 1285–1296.
  • Lombardo, D., Kiselev, M., and Caccamo, M., 2019. Smart nanoparticles for drug delivery application: development of versatile nanocarrier platforms in biotechnology and nanomedicine. Journal of nanomaterials, 2019, 1–26.
  • Lu, H., et al., 2016. Recent progress on nanostructures for drug delivery applications. Journal of nanomaterials, 2016, 1–12.
  • Ma, X. and Williams, R.O., 2018. Polymeric nanomedicines for poorly soluble drugs in oral delivery systems: an update. Journal of pharmaceutical investigation, 48, 61–75.
  • Majidi, F.S., et al., 2019. Investigating the effect of near infrared photo thermal therapy folic acid conjugated gold nano shell on melanoma cancer cell line A375. Artificial cells, nanomedicine, and biotechnology, 47 (1), 2161–2170.
  • Mohamed, S.A., et al., 2017. Immobilization of horseradish peroxidase on Fe3O4 magnetic nanoparticles. Electronic journal of biotechnology, 27, 84–90.
  • Mostafa, E., et al., 2019. Centaurea pumilio L. extract and nanoparticles: a candidate for healthy skin. Colloids and surfaces. B, biointerfaces, 182, 110350.
  • Mourdikoudis, S., Pallares, R.M., and Thanh, N., 2018. Characterization techniques for nanoparticles: comparison and complementarity upon studying nanoparticle properties. Nanoscale, 10 (27), 12871–12934.
  • Narayan, R., et al., 2018. Mesoporous silica nanoparticles: a comprehensive review on synthesis and recent advances. Pharmaceutics, 10 (3), 118–E167.
  • Narsireddy, A., et al., 2015. Photosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy. International journal of nanomedicine, 10, 6865–6878.
  • Nemati, Z., et al., 2020. Isolation of cancer-derived exosomes using a variety of magnetic nanostructures: from Fe3O4 nanoparticles to Ni nanowires. Nanomaterials, 10 (9), 1662.
  • Nikam, N., et al., 2020. Liposomes: a novel drug delivery system: an overview. Asian journal of pharmaceutical research, 10 (1), 23–28.
  • Pardakhty, A., et al., 2011. Pharmacokinetic study of niosome-loaded insulin in diabetic rats. Daru, 19 (6), 404–411.
  • Paris, L., et al., 2018. From proof-of-concept material to PEGylated and modularly targeted ultrasound-responsive mesoporous silica nanoparticles. Journal of materials chemistry. B, 6 (18), 2785–2794.
  • Park, W., Heo, Y.J., and Han, D.K., 2018. New opportunities for nanoparticles in cancer immunotherapy. Biomaterials research, 22, 24.
  • Patel, J., et al., 2018. Targeted delivery of monoclonal antibody conjugated docetaxel loaded PLGA nanoparticles into EGFR overexpressed lung tumour cells. Journal of microencapsulation, 35 (2), 204–217.
  • Patel, R., Patel, A., and Patel, H., 2021. Stabilized amorphous state of riluzole by immersion-rotavapor method with synthesized mesoporous SBA-15 carrier to augment in-vitro dissolution. Journal of drug delivery science and technology, 61 (102270).
  • Patel, R., Rajesh, H., and Parikh, R., 2020. Intranasal delivery of topiramate nanoemulsion: Pharmacodynamic, pharmacokinetic and brain uptake studies. International journal of pharmaceutics, 585 (119486), 119486.
  • Patra, J.K., et al., 2018. Nano based drug delivery systems: recent developments and future prospects. Journal of nanobiotechnology, 16 (1), 71–104.
  • Perinelli, D.R., et al., 2019. PEGylated polylactide (PLA) and poly (lactic-co-glycolic acid) (PLGA) copolymers for the design of drug delivery systems. Journal of pharmaceutical investigation, 49 (4), 443–458.
  • PR Newswire: Global $200 Billion Opportunity for Nanoparticle Drug Delivery Market by 2024. Size, Current Trends, and Dynamics. 2021. Available from: https://www.prnewswire.com/news-releases/global-200-billion-opportunity-for-nanoparticle-drug-delivery-market-by-2024–-size-current-trends-and-dynamics-300633653.html
  • Pu, X., et al., 2019. Mesoporous silica nanoparticles as a prospective and promising approach for drug delivery and biomedical applications. Current cancer drug targets, 19 (4), 285–295.
  • Rab, S., et al., 2020. An update on the global vaccine development for coronavirus. Diabetes & metabolic syndrome, 14 (6), 2053–2055.
  • Rajchakit, U. and Sarojini, V., 2017. Recent developments in antimicrobial-peptide-conjugated gold nanoparticles. Bioconjugate chemistry, 28 (11), 2673–2686.
  • Rasmussen, M.K., Pedersen, J.N., and Marie, R., 2020. Size and surface charge characterization of nanoparticles with a salt gradient. Nature communications, 11 (1), 2337.
  • Rayavarapu, R.G., et al., 2007. Synthesis and bioconjugation of gold nanoparticles as potential molecular probes for light-based imaging techniques. International journal of biomedical imaging, 2007, 29817.
  • Rhodes, R. and Green, J., 2018. Nanoscale artificial antigen presenting cells for cancer immunotherapy. Molecular immunology, 98, 13–18.
  • Riaz, M., et al., 2018. Surface functionalization and targeting strategies of liposomes in solid tumor therapy: a review. International journal of molecular sciences, 19 (1), 195–222.
  • Rudramurthy, G.R., et al., 2016. Nanoparticles: alternatives against drug-resistant pathogenic microbes. Molecules, 21 (7), 836.
  • Ruong, N.P., et al., 2015. The importance of nanoparticle shape in cancer drug delivery. Expert opinion on drug delivery, 12 (1), 129–142.
  • Saeed, M., et al., 2019. Engineering nanoparticles to reprogram the tumor immune microenvironment for improved cancer immunotherapy. Theranostics, 9 (26), 7981–8000.
  • Saeed, R.M., Dmour, I., and Taha, M.O., 2020. Stable chitosan-based nanoparticles using polyphosphoric acid or hexametaphosphate for tandem ionotropic/covalent crosslinking and subsequent investigation as novel vehicles for drug delivery. Frontiers in bioengineering and biotechnology, 8, 4.
  • Safari, J. and Zarnegar, Z., 2014. Advanced drug delivery systems: nanotechnology of health design A review. Journal of Saudi chemical society, 18 (2), 85–99.
  • Santos, A., Veiga, F., and Figueiras, A., 2019. Dendrimers as pharmaceutical excipients: synthesis, properties, toxicity and biomedical applications. Materials, 13 (1), 65.
  • Sharma, A., et al., 2018. Targeting mitochondrial dysfunction and oxidative stress in activated microglia using dendrimer-based therapeutics. Theranostics, 8 (20), 5529–5547.
  • Shi, J., et al., 2020. Biofilm-encapsulated nano drug delivery system for the treatment of colon cancer. Journal of microencapsulation, 37 (7), 481–491.
  • Shnoudeh, A., et al., 2019. Synthesis, characterization, and applications of metal nanoparticles. In: Rakesh K. Tekade, ed.. Advances in pharmaceutical product development and research, biomaterials and bionanotechnology. Elsevier: Academic Press, 527–612.
  • Shore, D., et al., 2016. Electrodeposited Fe and Fe-Au nanowires as MRI contrast agents. Chemical communications, 52 (85), 12634–12637.
  • Silva, C.O., et al., 2019. Current trends in cancer nanotheranostics: metallic, polymeric, and lipid-based systems. Pharmaceutics, 11 (1), 22–40.
  • Singh, J., et al., 2018. ‘Green’ synthesis of metals and their oxide nanoparticles: applications for environmental remediation. Journal of nanobiotechnology, 16 (1), 84.
  • Singh, S., 2019. Nanomaterials exhibiting enzyme-like properties (nanozymes): current advances and future perspectives. Frontiers in chemistry, 7, 46.
  • Skoglund, S., et al., 2017. Difficulties and flaws in performing accurate determinations of zeta potentials of metal nanoparticles in complex solutions-Four case studies. PLOS one, 12 (7), e0181735.
  • Slepička, P., et al., 2019. Methods of gold and silver nanoparticles preparation. Materials, 13 (1), 1.
  • Svenson, S. and Tomalia, D.A., 2005. Dendrimers in biomedical applications-reflections on the field. Advanced drug delivery reviews, 57 (15), 2106–2129.
  • Swierczewska, M., et al., 2018a. Polysaccharide-based nanoparticles for theranostic nanomedicine. Advanced drug delivery reviews, 99 (Pt A), 70–84.
  • Swierczewska, M., Crist, R.M., and McNeil, S.E., 2018b. Evaluating nanomedicines: obstacles and advancements. Methods in molecular biology, 1682, 3–16.
  • Szpak, A., et al., 2013. Stable aqueous dispersion of superparamagnetic iron oxide nanoparticles protected by charged chitosan derivatives. Journal of nanoparticle research, 15 (1), 1372.
  • Tavallaie, R., et al., 2018. Nucleic acid hybridization on an electrically reconfigurable network of gold-coated magnetic nanoparticles enables microRNA detection in blood. Nature nanotechnology, 13 (11), 1066–1071.
  • Tomalia, D.A., et al., 1985. A new class of polymers: starburst-dendritic macromolecules. Polymer journal, 17 (1), 117–132.
  • Uchegbu, I.F. and Vyas, S.P., 1998. Non-ionic surfactant based vesicles (niosomes) in drug delivery. International journal of pharmaceutics, 172 (1–2), 33–70.
  • Wahlich, J., et al., 2019. Nanomedicines for the delivery of biologics. Pharmaceutics, 11 (5), 210.
  • Wang, C., et al., 2016a. Inflammation-triggered cancer immunotherapy by programmed delivery of CpG and anti-PD1 antibody. Advanced materials, 28 (40), 8912–8920.
  • Wang, F., et al., 2016b. Recent advances on inorganic nanoparticle-based cancer therapeutic agents. International journal of environmental research and public health, 13 (12), 1182.
  • Watkins, R., et al., 2015. Natural product-based nanomedicine: recent advances and issues. International journal of nanomedicine., 6010 (6055–6074).
  • Wu, C. and Chang, J., 2012. Mesoporous bioactive glasses: structure characteristics, drug/growth factor delivery and bone regeneration application. Interface focus, 2 (3), 292–306.
  • Xu, C., Lei, C., and Yu, C., 2019. Mesoporous silica nanoparticles for protein protection and delivery. Frontiers in chemistry, 7, 290.
  • Yanagisawa, T., et al., 1990. The preparation of alkyltriinethylaininonium–kaneinite complexes and their conversion to microporous materials. Bulletin of the chemical society of Japan, 63 (4), 988–992.
  • Yang, C., et al., 2018. Theranostic niosomes for efficient sirna/microrna delivery and activatable near-infrared fluorescent tracking of stem cells. ACS applied materials & interfaces, 10 (23), 19494–19503.
  • Yang, D., 2021. Application of nanotechnology in the COVID-19 pandemic. International journal of nanomedicine, 16, 623–649.
  • Zhang, J., et al., 2018. A concentration-dependent insulin immobilization behavior of alkyl-modified silica vesicles: the impact of alkyl chain length. Langmuir, 34 (17), 5011–5019.
  • Zhao, Z., et al., 2019. Delivery strategies of cancer immunotherapy: recent advances and future perspectives. Journal of hematology & oncology, 12 (1), 126.
  • Zhou, T., et al., 2018. Phasor-fluorescence lifetime imaging microscopy analysis to monitor intercellular drug release from a pH-sensitive polymeric nanocarrier. Analytical chemistry, 90 (3), 2170–2177.
  • Zielińska, A., et al., 2020. Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology. Molecules, 25 (16), 3731.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.